ESC Premium Access

Safety and Outcomes of Standard of Care Medications Withdrawal in Patients with Obstructive Hypertrophic Cardiomyopathy Treated with Aficamten in FOREST-HCM Trial

Congress Presentation

About the speaker

Doctor Ahmad Masri

Oregon Health & Science University Medical Group, Portland (United States of America)
12 presentations
0 follower

7 more presentations in this session

Effect of Aficamten on Cardiac Structure and Function in Patients with Obstructive Hypertrophic Cardiomyopathy: The SEQUOIA-HCM CMR Trial

Speaker: Doctor A. Masri (Portland, US)

Thumbnail

Effect of Aficamten on Patient-Reported Health Status in Obstructive Hypertrophic Cardiomyopathy: Results from SEQUOIA-HCM

Speaker: Doctor J. Spertus (Kansas City, US)

Thumbnail

Impact of Aficamten on Echocardiographic Cardiac Structure and Function in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy

Speaker: Doctor S. Hegde (Boston, US)

Thumbnail

Aortic valve replacement versus conservative treatment in asymptomatic severe aortic stenosis

Speaker: Associate Professor M. Banovic (Belgrade, RS)

Thumbnail

Sex-specific outcomes after transcatheter or surgical treatment of aortic valve stenosis: A subanalysis from the DEDICATE-DZHK6 trial

Speaker: Professor S. Bleiziffer (Bad Oeynhausen, DE)

Thumbnail

Access the full session

Trial updates and other studies in hypertrophic cardiomyopathy and aortic stenosis

Speakers: Doctor A. Masri, Doctor A. Masri, Doctor J. Spertus, Doctor S. Hegde, Associate Professor M. Banovic...
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations